SÖNMEZ, M. Et Al. 2021. Treatment with Venetoclax for Chronic Lymphocytic Leukemia with the Highest Known White Blood Cell Count: Safe and Effective. TURKISH JOURNAL OF HEMATOLOGY , vol.38, no.4 , 344-346.

SÖNMEZ, M., KESTANE, M., AKIDAN, O., ERKUT, N., & Bektas, Ö., (2021). Treatment with Venetoclax for Chronic Lymphocytic Leukemia with the Highest Known White Blood Cell Count: Safe and Effective. TURKISH JOURNAL OF HEMATOLOGY , vol.38, no.4, 344-346.

SÖNMEZ, MEHMET Et Al. "Treatment with Venetoclax for Chronic Lymphocytic Leukemia with the Highest Known White Blood Cell Count: Safe and Effective," TURKISH JOURNAL OF HEMATOLOGY , vol.38, no.4, 344-346, 2021

SÖNMEZ, MEHMET Et Al. "Treatment with Venetoclax for Chronic Lymphocytic Leukemia with the Highest Known White Blood Cell Count: Safe and Effective." TURKISH JOURNAL OF HEMATOLOGY , vol.38, no.4, pp.344-346, 2021

SÖNMEZ, M. Et Al. (2021) . "Treatment with Venetoclax for Chronic Lymphocytic Leukemia with the Highest Known White Blood Cell Count: Safe and Effective." TURKISH JOURNAL OF HEMATOLOGY , vol.38, no.4, pp.344-346.

@article{article, author={MEHMET SÖNMEZ Et Al. }, title={Treatment with Venetoclax for Chronic Lymphocytic Leukemia with the Highest Known White Blood Cell Count: Safe and Effective}, journal={TURKISH JOURNAL OF HEMATOLOGY}, year=2021, pages={344-346} }